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Proteomics data can supplement genome annotation efforts, for example being used to confirm
gene models or correct gene annotation errors. Here, we present a large-scale proteogenomics
study of two important apicomplexan pathogens: Toxoplasma gondii and Neospora caninum.
We queried proteomics data against a panel of official and alternate gene models generated
directly from RNASeq data, using several newly generated and some previously published MS
datasets for this meta-analysis. We identified a total of 201 996 and 39 953 peptide-spectrum
matches for T. gondii and N. caninum, respectively, at a 1% peptide FDR threshold. This
equated to the identification of 30 494 distinct peptide sequences and 2921 proteins (matches
to official genemodels) for T. gondii, and 8911 peptides/1273 proteins forN. caninum following
stringent protein-level thresholding. We have also identified 289 and 140 loci for T. gondii and
N. caninum, respectively, which mapped to RNA-Seq-derived gene models used in our analysis
and apparently absent from the official annotation (release 10 fromEuPathDB) of these species.
We present several examples in our study where the RNA-Seq evidence can help in correction
of the current gene model and can help in discovery of potential new genes. The findings
of this study have been integrated into the EuPathDB. The data have been deposited to the
ProteomeXchange with identifiers PXD000297and PXD000298.
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1 Introduction
Apicomplexa are obligate intracellular parasites that are of
greatmedical and veterinary importance. Keymembers in the
phylum include Plasmodium falciparum, the causative agent
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of malaria; Toxoplasma gondii, responsible for severe congen-
ital defects and causing fatalities in immunocompromised
patients; Cryptosporidium, causing waterborne diarrheal dis-
ease in humans; Babesia, tick transmitted hemoprotozoan
parasites that cause disease in cattle, horses, dogs, and hu-
mans; and finally, Eimeria and Theileria that account for se-
vere diseases of food-producing animals in the United King-
dom and Europe. Apicomplexans are unified by an apical
complex consisting of a cluster of apical secretory organelles
such as rhoptries and micronemes, an apical polar ring and
in some species a polarized microtubule organizing center
called the conoid [1]. Host cell invasion is a key event for
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survival and replication of these parasites, which is conducted
in a multistep process [2].
The genome information for these apicomplexan is main-
tained by the Eukaryotic Pathogen Database Resource Centre
(EuPathDB: http://eupathdb.org) [3]. EuPathDB is an um-
brella portal providing unified access to 11 specialized re-
sources such as ToxoDB, PlasmoDB, etc. EuPathDB main-
tains genome sequences and annotations for these species
along with a variety of pathogen genomics and functional ge-
nomics data and is an important resource for the apicomplexa
research community. Among the first resources available at
EuPathDB (formerly known as ApiDB back in 2005) was the
genome of Plasmodium falciparum, which was the first api-
complexan genome to be sequenced [4]. This was followed by
the sequencing efforts of many more apicomplexan species,
including several other Plasmodium species [5–10], several
strains of T. gondii [11],Neospora caninum [12], Eimeria tenella
[10, 11], Babesia bovis [13], Cryptosporidium [12, 14, 15], and
Theileria species [16,17]. The efforts to sequence the T. gondii
genome began in 2001 and ToxoDB release 2.0 had genome
data for the ME49 and RH strains from a BAC clone-end se-
quencing project, an 8x random shotgun genome sequence,
and expressed sequence tag (EST) assemblies [18]. The high-
quality draft sequences and annotations for ME49, GT1, and
VEG strains were completed by 2008 [11]. There are con-
siderable manual curation efforts undertaken at EuPathDB
and by the wider Toxoplasma community to produce high-
quality gene models, as well as semi-automated reannotation
based on experimental data. The high-quality genome of the
closely related Coccidian parasite, N. caninum [12], has also
been released recently, and the currentN. caninum genemod-
els were assembled using large-scale RNA-Seq datasets as a
framework.
In this manuscript, we focus our attention on the current
annotations of T. gondii and N. caninum only. We aim to
study if proteomic evidence when used in conjunction with
RNA-Seq evidence can help improve the current annotation
of these species. The current genemodel of T. gondii includes
evidences from a number of previous MS-based studies per-
formed to identify the proteome of T. gondii. These studies
were typically based on the RH strain, which grows well and
gives a high yield, and therefore is a well-accepted model for
experimental studies. The first proteome studies either con-
centrated on studying a small number of tachyzoite proteins
in detail by 2DE separation [19, 20] or on studying subpro-
teomes of rhoptry organelles [21], the apical complex [22],
and the excreted-secreted proteome [23] of T. gondii. Themul-
tiplatform (2D electrophoresis, gel-LC linked MS/MS, and
MudPIT) analysis of T. gondii tachyzoite proteome by Xia
et al. [24] was the first global proteome analysis of T. gondii.
The peptide evidence from this study was instrumental in
the refinement of annotation of the genome including cor-
rect assignment of exon–intron boundaries [24]. A proteomic
analysis of cytosolic and membrane fractions of T. gondii
tachyzoites and the validation of gene models (TigrScan,
TwinScan, Glimmer, and ToxoDB Release 4, NCBI nonre-
dundant protein database) with EST and peptide evidence
data by Dybas et al. showed 31–42% false negative rate for
various gene models [25]. These were followed by two inde-
pendent analyses of the proteome of oocysts and sporozoites
of T. gondii [26, 27]. All these data amount to a coverage of
about 68% of predicted proteome of T. gondii [28]. The only
proteome data publicly available to date for N. caninum in-
clude a gel electrophoresis based study identifying 26 differ-
entially expressed proteins during tachyzoite to bradyzoite
differentiation [29] and the analysis of the subproteome of
rhoptry organelles [30, 31]. The RNA-Seq evidences on the
other hand have recently become available and have been in-
cluded in the current genemodels ofT. gondii andN. caninum
at ToxoDB. There has been availability of some published
[32, 33] and unpublished RNA-Seq datasets (http://toxodb
.org/toxo/getDataset.do?display=detail) for both T. gondii and
N. caninum that were used in the annotation.
Proteomics and RNA-Seq data provide complimentary evi-
dence sets that can be exploited together for improvement in
genome annotation. Next-generation sequencing techniques
are already playing an increasingly important role in genome
annotation. However, it is still difficult to unequivocally de-
termine if a predicted gene actually produces a protein, or
whether a predicted alternative splice of RNA is translated
into protein. MS-derived proteomics data can play a direct
role in genome annotation (proteogenomics), providing ev-
idence that a given “official gene model” encodes a protein
product, that a noncanonical (alternative) gene prediction is
more likely to be correct, or that peptide evidence supports the
discovery of new ORFs. Proteogenomics-based annotations
utilize high-throughput MS/MS-based proteomic techniques
to identify proteins present in a sample [34–36]. There are es-
sentially four different ways of identifying peptide-spectrum
matches from MS/MS: sequence database search [37, 38], de
novo sequencing [39, 40], tag search [41, 42], and spectral li-
brary search [43, 44]. De novo sequencing does not require a
sequence database to search against and thus could in theory
be used to identify new peptides/proteins, but the error rates
are generally too high for practical use in proteogenomics.
The remaining three techniques are fundamentally depen-
dent on the quality of the underlying database for identifying
peptide sequences, with the sequence database search tech-
nique being the most common among them. The protein
sequence databases are derived from gene annotations and
a peptide sequence can only be identified by these methods
if the corresponding gene sequence has been predicted cor-
rectly. The construction of a search database requires careful
planning and one can simultaneously test a panel of gene
models by combining evidences from independent computa-
tional and experimental sources.Genemodels can differ from
each other at a given locus in various ways, including predic-
tion of start codon, presence–absence of coding regions, or
precise intron–exon boundaries.
This manuscript takes a proteogenomics approach
for studying the existing annotations of T. gondii and
N. caninum, where we queried MS/MS datasets from eight
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different experiments using sequence databases comprising
official gene models and high-quality RNA-Seq-assisted pre-
dictions. For this study, we reanalyzed a number of published
datasets for T. gondii [24] and generated new high-throughput
MS/MS datasets for both T. gondii and N. caninum. Apart
from the protein identifications, we show that how this pro-
teogenomics approach can provide a useful contribution in
improving genome annotations of these species and can lead
to discovery of novel genes. The “official” gene models for
T. gondii and N. caninum were obtained from the latest re-
leases available at EuPathDB and the RNA-Seq predictions
were produced by the data available at the same repository.
The proteomic identifications against the official genemodels
provide evidence for genes that result into a protein product,
establish the validity of putative genes, and confirm predicted
splicing events. Identifications against the RNA-Seq-based
models on the other hand identify putative novel genes that
haveRNA-Seq evidence to support thembut aremissing from
the official release, differ in the splicing of exons, or show al-
ternate splicing from the canonical prediction. For both the
species, we identified a large number of proteins and several
targets for improvement in the current available annotation.
The datasets and results have been made available at Pro-
teomeXchange [45] and EuPathDB.
2 Materials and methods
2.1 Sample preparation and datasets
2.1.1 Toxoplasma gondii datasets
Datasets of RH strain of T. gondii 1DE, 1DE of soluble and
insoluble fractions (1DE SFIF), 2DE, and multidimensional
protein identification technology (MudPIT) were created for a
previously published T. gondii proteomics study [24]. Briefly,
for 1DE, 1DE SFIF, and 2DE, T. gondii RH tachyzoites were
separated either by 1D SDS-PAGE on a 12% v/v acrylamide
gel or 2DE using pH 4–7 linear gradient and pH 3–10 non-
linear gradient strips. In total, 129 contiguous gel slices from
the1DE experiment, 50 contiguous gel slices from the 1DE
SFIF experiment, and 1217 gel spots from the 2DE experi-
ments were collected and digested with trypsin. The peptide
mixtures were then analyzed on an LC-MS/MS platform—an
LTQ ion trap mass spectrometer (Thermo-Electron, Hemel
Hempstead, UK) coupled online to a Dionex Ultimate 3000
(Dionex Company, Amsterdam, The Netherlands) HPLC sys-
tem. For the T. gondii MudPIT experiment, five tris-soluble
replicates and four tris-insoluble samples of T. gondii RH
tachyzoite were each subjected to MudPIT analysis using a
quaternary Agilent 1100 series HPLC coupled to an LTQ-
ion trap mass spectrometer (Thermo, San Jose, CA, USA)
with a nano-LC ESI source. Datasets of T. gondii “Orbitrap
whole cell lysate” and “Orbitrap 1DE” were newly created
for this study using previously published sample preparation
and MS protocols [46]. These datasets were generated from
RH parasites in order to be consistent with the previously
published datasets. In the “Orbitrap whole cell lysate” ex-
periment, T. gondii RH tachyzoite proteins were solubilized
and tryptically digested. In the Orbitrap 1DE experiment, T.
gondii RH tachyzoites were separated by 1D SDS-PAGE on
a 12% v/v acrylamide gel, from which 16 gel bands were ex-
cised and digested with trypsin. The digests were then pooled
into eight samples for LC-MS/MS analysis. Peptide mixtures
from both experiments were analyzed by online nanoflow
LC using the nanoACQUITY-nLC system (Waters MS tech-
nologies, Manchester, UK) coupled to an LTQ-Orbitrap Ve-
los (ThermoFisher Scientific, Bremen, Germany) mass spec-
trometer equipped with the manufacturer’s nanospray ion
source.
2.1.2 Neospora caninum datasets
Datasets of N. caninum Orbitrap 1DE and Orbitrap 1DE-2
were collected from N. caninum LIV strain tachyzoites using
the similar protocol described in T. gondii datasets. Briefly,
8 and 14 gel slices were, respectively, excised from Orbitrap
1DE and Orbitrap 1DE-2 experiments. Samples were then
tryptically digested and analyzed by online nanoflow LC us-
ing the nanoACQUITY-nLC system (Waters MS technolo-
gies) coupled to an LTQ-Orbitrap Velos (ThermoFisher Sci-
entific) mass spectrometer equipped with themanufacturer’s
nanospray ion source.
It is important to note that all datasets were generated from
single life cycle stages of the parasites, where not all proteins
are expected to be expressed.
2.2 Proteogenomic analysis pipeline
The proteogenomics analysis of the above dataset was
performed by an automated software pipeline, the Pro-
teoAnnotator (http://www.proteoannotator.org/), developed
in our group. ProteoAnnotator is an open-source, platform-
independent, toolkit for proteogenomics, which is compli-
ant with formats from the Proteomics Standards Initiative
[47, 48]. The pipeline starts with genomic coordinates for
genemodels (GFF3 (generic file)) format, andmass spectra in
MGF (MASCOT Generic) format. ProteoAnnotator embeds
open-source search engines OMSSA [49] and X!Tandem [50],
which are accessed via the SearchGUI wrapper [51]. Postpro-
cessing is performed to control for FDR at the peptide level,
followed by a bespoke protein inference algorithm/scoring
approach, which is able to score the strength of evidence for
improvements to gene models at a given locus and assem-
ble peptides into protein groups. For general identifications
of protein groups—1% FDR is implemented. For (protein
group) identifications that suggest improvements to the cur-
rent genemodels, 5%FDR threshold is applied—asdiscussed
in the ProteoAnnotator publication [47].
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2.3 MS/MS search parameters
2.3.1 Search parameters
The search parameters for all the datasets were fixed modifi-
cation of carbamidomethylation of cysteine, variable modifi-
cation of acetylation of the protein n-terminus, pyro-glu from
n-terminal E, pyro-glu from n-terminal Q, and oxidation of
methionine. A double missed trypsin cleavage was allowed.
The product tolerance was set as ±0.5 Da and the precur-
sor tolerance as 5 ppm and ±0.5 Da for Orbitrap and LTQ,
respectively.
2.3.2 Gene models
The MS data for T. gondii and N. caninum were searched
against the protein database assembled from two different
sources: the official gene models and predicted gene models
supported by RNA-Seq evidences. The official gene models
(release 10 - January 30, 2014) were obtained fromEuPathDB.
The genemodel for T. gondiiwas obtained fromhttp://toxodb
.org/common/downloads/release-10.0/TgondiiME49/gff/
data/ and the N. caninum official model was obtained
from http://toxodb.org/common/downloads/release-10.0/
NcaninumLIV/gff/data/. At the time of submission of this
manuscript, the latest official gene models are available as
release 12 (September 10, 2014). However, releases 10 and
12 are identical in terms of protein counts and sequences.
The RNA-Seq-assisted alternate gene model was generated
using a version of CRAIG (default parameters) [52] that
integrates RNA-Seq data available at http://toxodb.org/. The
RNA-Seq data were encoded as features derived from the
genomic mapping of RNA-Seq read libraries as performed
by GSNAP version 2013-08-19 (default parameters) [53]. Fol-
lowing the same basic strategy as in [52], we obtained
a set of gene predictions for each existing library. We
sought completeness by forcing CRAIG to predict at least
one gene model for each biologically significant junction.
Junctions with conflicting evidence, that is junctions that
overlap other junctions, are deemed biologically significant
when their support is at least 20% of the highest support
found in any overlapping junction. Junctions with no
conflicts are biologically significant when they are sup-
ported by at least three reads mapping to the region. The
RNA-Seq compliant version of CRAIG is unpublished at
the time of preparing this manuscript, but the binaries
for the current version are available at http://roos8core
.bio.upenn.edu/abernal/craig/craig-2.1.tar.gz. The search
database was prepared by concatenating these genemodels to
the official gene models. The database was further appended
by decoy sequences with a target–decoy ratio of 1:1 to create
a final search database for performing the MS/MS searches.
We have provided these databases in the ProteomeXchange
submissions.
2.3.3 Functional analysis
Sequences from identifiedRNA-Seq-derived genemodel with
additional peptide evidence as well as overlapping official
gene models were analyzed using InterProScan 5 [54]. Ex-
amples where additional domains and functional signatures
identified in the RNA-Seq-derived gene model were fur-
ther analyzed and annotated using Clustal Omega [55] and
ToxoDB.
3 Results and discussion
Table 1 presents the composition of each gene model in
terms of number of predicted gene sets and the total amino
acid count. It also presents the total number of proteins
identified by our analysis of these datasets for each set of
gene models, summarized across all experiments. In order
to count the total number of proteins, we selected only a
single representative protein from grouped isoforms, where
ambiguity was present in peptide to protein inference as per
the ProteoGrouper algorithm in [47]. To our knowledge, the
total number of official proteins identified for both T. gondii
and N. caninum is the largest set of proteins with MS/MS
evidence reported in any single study. Our analysis identifies
35% of the total protein coding genes and 50% of the
total proteins with proteomic evidence reported for ME49
(http://toxodb.org/toxo/showRecord.do?name=Organism
RecordClasses.OrganismRecordClass&source_id=tgonME49
&project_id=ToxoDB). There is no proteomics evidence
available forN. caninum, so this is the first study where we re-
port 1273 proteins with MS/MS evidence (http://toxodb.org/
toxo/showRecord.do?name=OrganismRecordClasses.Organ
ismRecordClass&source_id=ncanLIV&project_id=ToxoDB).
Our analysis also suggests that there are 289 and 140
potential loci for T. gondii and N. caninum, respectively,
that have support from RNA-Seq and proteomics data but
have incorrect gene models or are missing from the current
annotation. When further stringent thresholding (5% FDR)
is applied, there are 191 and 101 proteins identified from
the RNA-Seq-derived gene models for T. gondii and N.
caninum, respectively, as discussed in “Identifications From
the RNA-Seq models.”
The complete list of identified proteins, along with
corresponding peptide hits and locations, is provided in the
result files available at ProteomeXchange. Additionally, all
results have been loaded into EuPathDB, aligned against
the most recent genome release. An example region on
chromosome VIII can be viewed at: http://toxodb.org/cgi-
bin/gbrowse/toxodb/?start=5924028;stop=5974027;ref=TG
ME49_chrVIII;width=800;version=100;flip=0;grid=1;id=
d6546393407f30e0e323ffd34a77b61a;l=peptide_ToxoDB_18
db2e_http_www.proteoannotator.org_datasets_Toxo10_offic
ial_peptides.gff_1%1EGene—where datasets can be
viewed alongside RNA-Seq and other large-scale datasets
(On GBrowse—Click “Select Tracks,” “Supplementary
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Table 1. The composition of gene models and the number of representative proteins identified in total across our full data collection
Species Gene model Total
database
entries
Total amino
acid count
Representative
proteins
identified as
group leaders
a)
Alternate loci
with q-value <
0.05
T. gondii Official 8322 6 669 204 2921 0
RNA-Seq 86 699 37 847 722 289 191
N. caninum Official 7122 6 054 032 1273 0
RNA-Seq 13 777 8 158 875 140 101
a) A “representative protein” can encompasses more than one record (protein) from the protein database, incorporating the set of proteins
that share the same set or subset of peptide identifications to avoid double counting of proteins with no independent evidence.
Data Provided by Users”—All On). Alternatively, the
results can be loaded to any desktop-based genome
browser by loading the GFF3 file from http://www
.proteoannotator.org/datasets/Toxo10_official_peptides.gff.
3.1 Identifications from the RNA-Seq models
The conflict where a PSM identified a peptide that belonged
to both the official and RNA-Seq models was resolved by
using the ProteoGrouper algorithm in ProteoAnnotator, in
which identifications are assembled into protein groups. The
protein groups are assigned two types of score (see [47]):
(i) the overall score for the (protein ambiguity) group (PAG
Score) and (ii) the strength of evidence supporting identified
loci not from the official gene models (noncanonical gene
model score). In the case of a tie between an official model
and an identification from the alternative (RNA-Seq) mod-
els (same set of peptides), the protein group leader is by
default assigned as the official model and the noncanonical
gene model score = 0. The sum of peptide scores uniquely as-
signed to the group is used to generate the PAG Score. The
protein group list is ordered by PAG Score (including targets
and decoys), and a 1% FDR (protein group-level) threshold
is applied. This basis was used to generate the figures in
Table 1 for official gene models. For any groups where pep-
tides have uniquely been assigned to an RNA-Seq-derived
protein, the noncanonical genemodel score is the sumof all pep-
tide scores within the group assigned to models other than
the official gene models. All “decoy” peptides are by default
not assigned to an official gene model, and thus contribute
to the noncanonical gene model score for the corresponding de-
coy protein group list. As such, all decoy peptides/proteins
have noncanonical gene model score >0. The protein group list
is separately ordered by noncanonical gene model score and
a 5% FDR (q-value) threshold is applied (since this is con-
servatively calculated from all decoy peptides/proteins, this
step ensured that the weak identifications from the alter-
nate models are filtered out—e.g. those supported by only a
single weak peptide identification matched to one RNA-Seq
model), giving a list of significant alternate loci supporting
evidence for improvement in the genome annotation. The
q-value threshold at 5% resulted in identification of 191 and
101 proteins from the RNA-Seq-derived gene model for T.
gondii andN. caninum, respectively. There are number of pro-
teins identified with high noncanonical gene model scores that
have not been assigned a chromosome, for example tgondii-
rna.Reid_tachy.day3.gene1112 (5 noncanonical peptides),
tgondii-rna.Reid_tachy.day4.gene797 (17 noncanonical pep-
tides), tgondii-rna.Saeij_Jeroen_strains.COUGAR.gene1934
(15 noncanonical peptides), etc. These identifications are ex-
amples of those cases that are missing from the official an-
notation and are potential candidates for new genes.
Figures 1–3 present three different cases selected from the
list of alternate identifications that suggest various improve-
ments for the official gene model, including a different start
codon, an extended gene model, and a different splicing site.
Figure 1 presents a case of different start site picked
by our analysis from two different datasets where two
genes, TGME49_269442 and TGME49_269438, on chro-
mosome VIII are in the immediate proximity of each
other. The last exon of TGME49_269442 is within 116
base pairs of the first exon of TGME49_269438. The
predicted gene model suggests a single transcript—tgondii-
rna.Saeij_Jeroen_strains.CEPdelta.gene1305—that spans
across the boundaries of both the genes. The presence of
peptide evidence for this transcript suggests that these gene
boundaries may be wrong. The official gene is annotated as
putative calmodulin, a calcium-binding messenger protein.
Calcium plays a critical role in several parasite-specific
functions including host cell invasion and egress [56]. As
shown in Fig. 1C, domain analysis suggested that, with a
different starting site, the RNA-Seq-derived model possesses
a complete EF-hand domain pair where the official model
only includes a single EF-hand unit. Pairing of EF hands
is thought to stabilize the protein and increase the affinity
toward calcium [57], the RNA-Seq-derived model here may
present a biologically more complete calmodulin protein
with better calcium-binding efficiency.
A case of an extended gene model is shown in
Fig. 2 where the official gene model for TGME49_324800
has no domain detected in domain analysis, but has been
annotated as tryptophanyl-tRNA synthetase. The RNA-Seq-
derived model has both Threonyl/alanyl tRNA synthetase,
class II-like, putative editing domain (in red, position 12–
139, IPR018163), and a Rossmann-like alpha/beta/alpha
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Figure 1. Peptide evidence indicating an alternate start codon. RNA-Seq-derived gene model tgondii-
rna.Saeij_Jeroen_strains.CEPdelta.gene1305 was identified in our analysis, which has a different starting site to the official gene
model TGME49_269442. (A) GBrowse screenshot of the alignment of the official gene model, RNA-Seq-derived gene model, and peptides
identified. (B) Sequence alignment of official and RNA-Seq-derived gene model. (C) Comparison of InterProScan results between official
and RNA-Seq-derived models where a complete EF-hand domain pair was identified in the RNA-Seq-derived model.
sandwich fold (IPR014729) detected. The official model lies
between the end of the first domain and beginning of the
second domain, which might be the reason for the current
product name annotation. With an extended gene structure,
the RNA-Seq-derived model has two full domains to sup-
port the product name and to make the annotation more
complete.
Our analysis has also detected cases for different splice
sites, an example for gene TGVEG_295125 is shown in
Fig. 3. TGVEG_295125 is annotated as rhoptry protein
ROP4 with two exons (see Fig. 3A). However, sequence
alignment has shown that an ORF (ToxoDB: KI544509-5-
1423859-1422096) can be found to expand the full length
of the gene, including the intron region. In fact, 17
nonofficial peptides were identified from five datasets
that mapped to the intron region of the official gene
model (Fig. 3B), which suggested that RNA-Seq-derived
model tgondii-rna.Saeij_Jeroen_strains.VEG.gene444 repre-
sents the actual protein expressed in this region. Interest-
ingly, tgondii-rna.Saeij_Jeroen_strains.VEG.gene444 aligns
perfectly with ROP4 gene sequence deposited in GenBank
(version: AAU87405.1; GI: 52788873), which was indepen-
dently identified by cross-reacting mAbs [58]. Together, our
analysis provides evidence that TGVEG_295125 should be
annotated as a single exon gene with no splice site in the
middle.
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Figure 2. Peptide evidence indicating a suggested extension to the official gene model. RNA-Seq-derived gene model tgondii-
rna.Saeij_Jeroen_strains.TgCATBr5.gene3708 was identified in our analysis that has a different starting site to the official gene model
TGME49_324800. (A) Sequence alignment of official and RNA-Seq-derived gene model where peptides identified in both models are
colored in blue and peptides identified only in RNA-Seq-derived model are colored in red. (B) Results from InterProScan indicate rel-
evant domains detected in the RNA-Seq-derived gene model that are missing in the official gene model that has been annotated as
tryptophanyl-tRNA synthetase.
The expression evidence of alternate gene structures pro-
vided by our analysis allowedus to identify new functional fea-
tures in a gene. For example, a TRAM/LAG1/CLN8homology
domain was identified in RNA-Deq derived model tgondii-
rna.Gregory_VEG_mRNA.hour16.gene5326, suggesting ad-
ditional functions of the official gene TGME49_295080,
which is annotated as a hypothetical protein. Signal pep-
tides were also identified in RNA-Seq-derived models,
which were missing in the equivalent official gene models,
such as tgondii-rna.Saeij_Jeroen_strains.BOF.gene2384 ver-
sus TGME49_214220 and tgondii-rna.Gregory_VEG_mRNA
.hour16.gene1072 versus TGME49_254470, both of which
were annotated as hypothetical proteins. These additional
features identified in our study would provide valuable in-
formation for functional annotation of the genome.
3.2 Description of available result files
The MS/MS datasets and result files are available at the
ProteomeXchange Consortium with the dataset identifiers
PXD000297 and PXD000298. There are six types of data
files submitted at ProteomeXchange for both T. gondii and
N. caninum datasets. These files are of types—raw MSMS
files (.raw), peak list files (.mgf), search results in native
OMSSA and X!Tandem formats (.omx and .xml), search re-
sults in mzIdentML format with various scores (.mzid), an-
notation files with integrated peptide evidences (.gff), and
summary files (.csv). Each file name starts with a prefix
representing the dataset it belongs to. The linkage is also
available via ProteomeXchange interface. The datasets for T.
gondii are denoted by self-explanatory prefixes—1DE, 2DE,
MPIT, Orb-1DE, and Orb-WL. The datasets for N. caninum
are prefixed by NORB-1 and NORB-2 for Orbitrap 1DE and
Orbitrap 1DE-2 datasets, respectively. The GFF and CSV
(comma separated values) files are of direct relevance to
annotators. The GFF files exist in two forms, one for the
peptides mapped on the official model, and another for the
peptides mapped on the RNA-Seq model. The GFFs that
correspond to the official model are named with a suffix
“_gff_A,” whereas the GFFs corresponding to the RNA-Seq
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Figure 3. Peptide evidence indicating a different splicing site to the official gene model. RNA-Seq-derived gene model tgondii-
rna.Saeij_Jeroen_strains.VEG.gene444 was identified in our analysis that has a different starting site to the official gene model
TGVEG_295125. (A) GBrowse screenshot showing ORF KI544509-5-1423859-1422096 expands the intron region of the official gene model.
(B) Sequence alignment of official and RNA-Seq-derived gene model where peptides identified in both models are colored in blue and
peptides identified in the intron region of official gene model are colored in red.
model are named with a suffix “gff_B,” in same manner
as our search database was prepared. As an example, the
GFFs produced by searching the 1DE dataset for T. gondii
are named as 1DE_mapped_gff_A.gff (for official model) and
1DE_mapped_gff_B.gff (for RNA-Seq model). These GFFs
can be directly loaded in a genome browser of choice, or can
be uploaded at the GBrowse custom track interface of Tox-
oDB (http://toxodb.org/cgi-bin/gbrowse/toxodb/). There are
five CSV files for each dataset and are prefixed in the same
manner as above to identify the dataset they belong to. The
type of information in the CSV files can be identified by the
particular suffixes the files have in their names as described
in [47]. A list of representative proteins from each experiment
and the final counts are provided in the Supporting Informa-
tion Files 1 and 2 for T. gondii and N. caninum, respectively.
The identifications from the RNA-Seq-derived model can be
loaded at the GBrowse interface of ToxoDB using Support-
ing Information File 3. The file contains the predicted tran-
scripts and identified peptides. The InterProScan results for
the RNA-Seq-derived identifications are listed in Supporting
Information File 4. A genome-wide distribution plot of sug-
gested correction sites for T.gondii can be seen in Supporting
Information File 5.
4 Concluding remarks
MS-based proteomics has an important role to play in
successful annotation of gene models. Our analysis of T.
gondii and N. caninum not only identifies many known
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protein-coding genes but also provides a framework for vali-
dation of hypothetical and putative proteins. Our study pro-
vides evidence that further improvements to the existing gene
annotationmodels for these species are possible, and helps in
pin-pointing the locations in the genome, which may require
a revision. The inclusion of RNA-Seq predictions in our pro-
teogenomics approach enables us to harness the combined
power of genomics and proteomics data for discovery of new
genes that are not part of the current annotation. We an-
ticipate that the inclusion of this evidence into the routine
curation process will assist in the generation of accurate gene
models released at the genome databases for these important
species.
An important aspect of our approach is the reproducibility
of the entire process facilitated by the availability of the Pro-
teoAnnotator software toolkit. The tools and results developed
for this study have been installed locally at the EuPathDB
database and will shortly be used as part of a standard build
pipeline for adding proteomics data to the various databases
held within different subsites. The findings of our study for
both T. gondii and N. caninum genomes are also integrated
on the ToxoDB and are part of standard query interface. The
full dataset and result files are available in public domain at
ProteomeXchange.
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